<DOC>
	<DOCNO>NCT01104948</DOCNO>
	<brief_summary>This dose block-randomized , double-blind , placebo-controlled , single/multiple dosing , dose-escalation study . The study design describe relationship multiple dose pharmacokinetic parameter DA-8031 well safety profile .</brief_summary>
	<brief_title>A Study Characterize Pharmacokinetics DA-8031 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>2045 year healthy male subject Body weight :6090kg , BMI 18.525 show SBP ( Systolic Blood Pressure ) = &lt; 100mmHg &gt; =140mmHg , DBP ( Diastolic Blood Pressure ) = &lt; 60mmHg &gt; =90mmHg , tachycardia ( PR ( Pulse Rate ) &gt; =100times/min ) history drug abuse show positive drug abuse cotinine urine screening smoker</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>